References

Aguzzi A, Calella AM Prions: protein aggregation and infectious diseases. Physiol Rev. 2009; 89:1105-1152 https://doi.org/10.1152/physrev.00006.2009
Soto C, Satani N The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol Med. 2011; 17:14-24 https://doi.org/10.1016/j.molmed.2010.09.001
Smith A, Dickson M, Aitken J, Bagg J Contaminated dental instruments. J Hosp Infect. 2002; 51:233-235 https://doi.org/10.1053/jhin.2002.1213
Sushma B, Gugwad S, Pavaskar R, Malik SA Prions in dentistry: a need to be concerned and known. J Oral Maxillofac Pathol. 2016; 20:111-114 https://doi.org/10.4103/0973-029X.180961
Prusiner SB Shattuck lecture – neurodegenerative diseases and prions. N Engl J Med. 2001; 344:1516-1526 https://doi.org/10.1056/NEJM200105173442006
National CJD Research & Surveillance Unit (NCJDRSU), University of Edinburgh (5AD). 2025. https://cjd.ed.ac.uk/sites/default/files/2025-01/Latest%20NCJDRSU%20CJD%20Monthly%20Statistics.pdf (accessed May 2025)
Jayanthi P, Thomas P, Bindhu P, Krishnapillai R Prion diseases in humans: oral and dental implications. N Am J Med Sci. 2013; 5:399-403 https://doi.org/10.4103/1947-2714.115766
De Vita E, Ridgway GR, Scahill RI Multiparameter MR imaging in the 6-OPRI variant of inherited prion disease. AJNR Am J Neuroradiol. 2013; 34:1723-1730 https://doi.org/10.3174/ajnr.A3504
Mead S, Poulter M, Beck J Inherited prion disease with six octapeptide repeat insertional mutation – molecular analysis of phenotypic heterogeneity. Brain. 2006; 129:2297-2317 https://doi.org/10.1093/brain/awl226
Mental Capacity Act. 2005. https://www.legislation.gov.uk/ukpga/2005/9/contents (accessed April 2025)
Dental Sedation Teachers Group. Logbook of clinical experience in conscious sedation. 2015. www.dstg.co.uk/index.php/documents/document/dstg-logbook-of-clinical-experience-in-conscious-sedation/viewdocument/11 (accessed April 2025)
Wilson E, David A, MacKenzie N, Grant IS Sedation during spinal anaesthesia: comparison of propofol and midazolam. Br J Anaesth. 1990; 64:48-52 https://doi.org/10.1093/bja/64.1.48
World Health Organization. WHO infection control guidelines for transmissible spongiform encephalopathies: report of a WHO consultation. 1999. https://iris.who.int/handle/10665/66707 (accessed April 2025)
Department of Health. Decontamination. Health technical memorandum 01-05: decontamination in primary care dental practices. 2013. www.england.nhs.uk/wp-content/uploads/2021/05/HTM_01-05_2013.pdf (accessed April 2025)
Reuber M, Al-Din AS, Baborie A, Chakrabarty A New variant Creutzfeldt–Jakob disease presenting with loss of taste and smell. J Neurol Neurosurg Psychiatry. 2001; 71:412-413 https://doi.org/10.1136/jnnp.71.3.412
Cicciù M, Matacena G, Signorino F Relationship between oral health and its impact on the quality life of Alzheimer's disease patients: a supportive care trial. Int J Clin Exp Med. 2013; 6:766-772
Auerbacher M, Gebetsberger L, Kaisarly D Oral health in patients with neurodegenerative and cerebrovascular disease: a retrospective study. Disabil. 2023; 45:2316-2324 https://doi.org/10.1080/09638288.2022.2088866
Office for Health Improvement and Disparities, Department of Health and Social Care, NHS England and NHS Improvement. Delivering better oral health: an evidence-based toolkit for prevention. 2021. www.gov.uk/government/publications/delivering-better-oral-health-an-evidence-based-toolkit-for-prevention (accessed April 2025)
Mouth care matters. A guide for hospital healthcare professionals. 2019. https://mouthcarematters.hee.nhs.uk/wp-content/uploads/sites/6/2020/01/MCM-GUIDE-2019-Final.pdf (accessed April 2025)
Jepsen S, Blanco J, Buchalla W Prevention and control of dental caries and periodontal diseases at individual and population level: consensus report of group 3 of joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases. J Clin Periodontol. 2017; 44:S85-S93 https://doi.org/10.1111/jcpe.12687
Fried-Oken M, Mooney A, Peters B Supporting communication for patients with neurodegenerative disease. NeuroRehabilitation. 2015; 37:69-87 https://doi.org/10.3233/NRE-151241
Geddis-Regan A, Kerr K, Curl C The impact of dementia on oral health and dental care, part 2: approaching and planning treatment. Prim Dent J. 2020; 9:31-37 https://doi.org/10.1177/2050168420923862
Boyle CA, Lane H Sedation or general anaesthetic for special care patients?. Prim Dent J. 2020; 9:56-61 https://doi.org/10.1177/2050168420923870
Dougall A, Fiske J Access to special care dentistry, part 1. Access. Br Dent J. 2008; 204:605-616 https://doi.org/10.1038/sj.bdj.2008.457
Taberna M, Gil Moncayo F, Jané-Salas E The multidisciplinary team (MDT) approach and quality of care. Front Oncol. 2020; 10 https://doi.org/10.3389/fonc.2020.00085

The impact of hereditary prion disease on the provision of dental care

From Volume 52, Issue 6, June 2025 | Pages 392-398

Authors

Iona Turner

BDS, MFDS RCSEd, Specialty Dentist in Special Care Dentistry

Articles by Iona Turner

Email Iona Turner

Nabihah Hamid

BDS, Community Dental Officer

Articles by Nabihah Hamid

Natalie Bradley

BDS MFDS Dip SCD RCSEd

BDS, MFDS, MSc, DSCDMSCD RCSEd, Consultant in Special Care Dentistry; King's College Hospital NHS Foundation Trust, London

Articles by Natalie Bradley

Email Natalie Bradley

Abstract

Prion diseases, also known as transmissible spongiform encephalopathies, are progressive, fatal neurodegenerative diseases. Prion disease and dentistry has been subject to research owing to the significance of cross-contamination with dental instruments. This article discusses the provision of dental treatment for patients with prion disease, focusing on a patient with hereditary prion disease in a special care dental department.

CPD/Clinical Relevance: Patients with neurodegenerative encephalopathies, such as prion diseases, may require additional support with dental treatment.

Article

Prion diseases, also known as transmissible spongiform encephalopathies, are progressive, fatal neurodegenerative conditions.1,2 Prion disease and dentistry is an area of research that has been examined many times in the past owing to the significance of cross-contamination with dental instruments.3 Prions are very stable molecules, which make them difficult to denature with normal sterilization techniques.4 Because of this, it is important to consider the risk of transmission within the dental setting. There is limited information focusing on the specific subtype of hereditary prion diseases as well as the impact on affected patients in dental departments.

This article discusses the differences between prion diseases and the implications for the provision of patient-centred care. It reports on a case seen in a special care dental department of a patient with hereditary prion disease.

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available